Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025

SKU ID :QYR-13522554 | Published Date: 16-Jan-2019 | No. of pages: 109
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Laser Treatment 1.4.3 Anti-VEGF Injection 1.4.4 Anti-Inflammatory Treatment 1.4.5 Vitrectomy 1.5 Market by Application 1.5.1 Global Macular Edema Therapeutics Market Share by Application (2014-2025) 1.5.2 Cystoid Macular Edema (CME) 1.5.3 Diabetic Macular Edema(DME) 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Macular Edema Therapeutics Market Size 2.2 Macular Edema Therapeutics Growth Trends by Regions 2.2.1 Macular Edema Therapeutics Market Size by Regions (2014-2025) 2.2.2 Macular Edema Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Macular Edema Therapeutics Market Size by Manufacturers 3.1.1 Global Macular Edema Therapeutics Revenue by Manufacturers (2014-2018) 3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Macular Edema Therapeutics Key Players Head office and Area Served 3.3 Key Players Macular Edema Therapeutics Product/Solution/Service 3.4 Date of Enter into Macular Edema Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Macular Edema Therapeutics Market Size by Type (2014-2019) 4.2 Global Macular Edema Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Macular Edema Therapeutics Market Size (2014-2019) 5.2 Macular Edema Therapeutics Key Players in United States 5.3 United States Macular Edema Therapeutics Market Size by Type 5.4 United States Macular Edema Therapeutics Market Size by Application 6 Europe 6.1 Europe Macular Edema Therapeutics Market Size (2014-2019) 6.2 Macular Edema Therapeutics Key Players in Europe 6.3 Europe Macular Edema Therapeutics Market Size by Type 6.4 Europe Macular Edema Therapeutics Market Size by Application 7 China 7.1 China Macular Edema Therapeutics Market Size (2014-2019) 7.2 Macular Edema Therapeutics Key Players in China 7.3 China Macular Edema Therapeutics Market Size by Type 7.4 China Macular Edema Therapeutics Market Size by Application 8 Japan 8.1 Japan Macular Edema Therapeutics Market Size (2014-2019) 8.2 Macular Edema Therapeutics Key Players in Japan 8.3 Japan Macular Edema Therapeutics Market Size by Type 8.4 Japan Macular Edema Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Macular Edema Therapeutics Market Size (2014-2019) 9.2 Macular Edema Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Macular Edema Therapeutics Market Size by Type 9.4 Southeast Asia Macular Edema Therapeutics Market Size by Application 10 India 10.1 India Macular Edema Therapeutics Market Size (2014-2019) 10.2 Macular Edema Therapeutics Key Players in India 10.3 India Macular Edema Therapeutics Market Size by Type 10.4 India Macular Edema Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Macular Edema Therapeutics Market Size (2014-2019) 11.2 Macular Edema Therapeutics Key Players in Central & South America 11.3 Central & South America Macular Edema Therapeutics Market Size by Type 11.4 Central & South America Macular Edema Therapeutics Market Size by Application 12 International Players Profiles 12.1 Allergan 12.1.1 Allergan Company Details 12.1.2 Company Description and Business Overview 12.1.3 Macular Edema Therapeutics Introduction 12.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2014-2019) 12.1.5 Allergan Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Company Description and Business Overview 12.2.3 Macular Edema Therapeutics Introduction 12.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2014-2019) 12.2.5 Novartis Recent Development 12.3 Roche 12.3.1 Roche Company Details 12.3.2 Company Description and Business Overview 12.3.3 Macular Edema Therapeutics Introduction 12.3.4 Roche Revenue in Macular Edema Therapeutics Business (2014-2019) 12.3.5 Roche Recent Development 12.4 Regeneron Pharmaceuticals 12.4.1 Regeneron Pharmaceuticals Company Details 12.4.2 Company Description and Business Overview 12.4.3 Macular Edema Therapeutics Introduction 12.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019) 12.4.5 Regeneron Pharmaceuticals Recent Development 12.5 Pfizer 12.5.1 Pfizer Company Details 12.5.2 Company Description and Business Overview 12.5.3 Macular Edema Therapeutics Introduction 12.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2014-2019) 12.5.5 Pfizer Recent Development 12.6 Bayer 12.6.1 Bayer Company Details 12.6.2 Company Description and Business Overview 12.6.3 Macular Edema Therapeutics Introduction 12.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2014-2019) 12.6.5 Bayer Recent Development 12.7 Boehringer Ingelheim 12.7.1 Boehringer Ingelheim Company Details 12.7.2 Company Description and Business Overview 12.7.3 Macular Edema Therapeutics Introduction 12.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2014-2019) 12.7.5 Boehringer Ingelheim Recent Development 12.8 Bausch & Lomb 12.8.1 Bausch & Lomb Company Details 12.8.2 Company Description and Business Overview 12.8.3 Macular Edema Therapeutics Introduction 12.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2014-2019) 12.8.5 Bausch & Lomb Recent Development 12.9 Aciont 12.9.1 Aciont Company Details 12.9.2 Company Description and Business Overview 12.9.3 Macular Edema Therapeutics Introduction 12.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2014-2019) 12.9.5 Aciont Recent Development 12.10 ActiveSite Pharmaceuticals 12.10.1 ActiveSite Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Macular Edema Therapeutics Introduction 12.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019) 12.10.5 ActiveSite Pharmaceuticals Recent Development 12.11 Adverum Biotechnologies 12.12 Aerpio Therapeutics 12.13 Ampio Pharmaceuticals 12.14 Araim Pharmaceuticals 12.15 Astellas Pharma 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Macular Edema Therapeutics Key Market Segments Table Key Players Macular Edema Therapeutics Covered Table Global Macular Edema Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Macular Edema Therapeutics Market Size Market Share by Type 2014-2025 Figure Laser Treatment Figures Table Key Players of Laser Treatment Figure Anti-VEGF Injection Figures Table Key Players of Anti-VEGF Injection Figure Anti-Inflammatory Treatment Figures Table Key Players of Anti-Inflammatory Treatment Figure Vitrectomy Figures Table Key Players of Vitrectomy Table Global Macular Edema Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Cystoid Macular Edema (CME) Case Studies Figure Diabetic Macular Edema(DME) Case Studies Figure Macular Edema Therapeutics Report Years Considered Table Global Macular Edema Therapeutics Market Size 2014-2025 (Million US$) Figure Global Macular Edema Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Macular Edema Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Macular Edema Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Macular Edema Therapeutics Market Share by Regions 2014-2019 Figure Global Macular Edema Therapeutics Market Share by Regions 2014-2019 Figure Global Macular Edema Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Macular Edema Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Macular Edema Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Macular Edema Therapeutics Market Share by Manufacturers in 2018 Table Global Macular Edema Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Macular Edema Therapeutics Product/Solution/Service Table Date of Enter into Macular Edema Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Macular Edema Therapeutics Market Size Share by Type (2014-2019) Figure Global Macular Edema Therapeutics Market Size Market Share by Type (2014-2019) Table Global Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Macular Edema Therapeutics Market Size Share by Application (2014-2019) Figure Global Macular Edema Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Macular Edema Therapeutics Revenue Market Share by Application in 2018 Figure United States Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Macular Edema Therapeutics Market Share (2018-2019) Table United States Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Macular Edema Therapeutics Market Share by Type (2014-2019) Table United States Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Macular Edema Therapeutics Market Share by Application (2014-2019) Figure Europe Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Macular Edema Therapeutics Market Share (2018-2019) Table Europe Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Macular Edema Therapeutics Market Share by Type (2014-2019) Table Europe Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Macular Edema Therapeutics Market Share by Application (2014-2019) Figure China Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Macular Edema Therapeutics Market Share (2018-2019) Table China Macular Edema Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Macular Edema Therapeutics Market Share by Type (2014-2019) Table China Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Macular Edema Therapeutics Market Share by Application (2014-2019) Figure Japan Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Macular Edema Therapeutics Market Share (2018-2019) Table Japan Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Macular Edema Therapeutics Market Share by Type (2014-2019) Table Japan Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Macular Edema Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Macular Edema Therapeutics Market Share (2018-2019) Table Southeast Asia Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Macular Edema Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Macular Edema Therapeutics Market Share by Application (2014-2019) Figure India Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Macular Edema Therapeutics Market Share (2018-2019) Table India Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Macular Edema Therapeutics Market Share by Type (2014-2019) Table India Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Macular Edema Therapeutics Market Share by Application (2014-2019) Figure Central & South America Macular Edema Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Macular Edema Therapeutics Market Share (2018-2019) Table Central & South America Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Macular Edema Therapeutics Market Share by Type (2014-2019) Table Central & South America Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Macular Edema Therapeutics Market Share by Application (2014-2019) Table Allergan Company Details Table Allergan Revenue in Macular Edema Therapeutics Business (2014-2019) (Million US$) Figure Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Allergan Recent Development Table Novartis Company Details Table Novartis Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Novartis Recent Development Table Roche Company Details Table Roche Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Roche Recent Development Table Regeneron Pharmaceuticals Company Details Table Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Regeneron Pharmaceuticals Recent Development Table Pfizer Company Details Table Pfizer Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Pfizer Recent Development Table Bayer Company Details Table Bayer Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Bayer Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Boehringer Ingelheim Recent Development Table Bausch & Lomb Company Details Table Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Bausch & Lomb Recent Development Table Aciont Company Details Table Aciont Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table Aciont Recent Development Table ActiveSite Pharmaceuticals Company Details Table ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$) Figure ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019) Table ActiveSite Pharmaceuticals Recent Development Table Adverum Biotechnologies Company Details Table Aerpio Therapeutics Company Details Table Ampio Pharmaceuticals Company Details Table Araim Pharmaceuticals Company Details Table Astellas Pharma Company Details Table Global Macular Edema Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Macular Edema Therapeutics Market Size Share by Regions (2019-2025) Figure Global Macular Edema Therapeutics Market Size Share by Regions in 2025 Figure United States Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Macular Edema Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Macular Edema Therapeutics Market Size by Product (2019-2025) Figure Global Macular Edema Therapeutics Market Size by Product in 2025 Table Global Macular Edema Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Macular Edema Therapeutics Market Size by Application (2019-2025) Figure Global Macular Edema Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Allergan Novartis Roche Regeneron Pharmaceuticals Pfizer Bayer Boehringer Ingelheim Bausch & Lomb Aciont ActiveSite Pharmaceuticals Adverum Biotechnologies Aerpio Therapeutics Ampio Pharmaceuticals Araim Pharmaceuticals Astellas Pharma
  • PRICE
  • $3900
    $7800

Our Clients